TABLE 1.

Inhibitor binding to EGFR WT and mutant kinase domains

Kinase domain	KD
	Gefitinib	Erlotinib
	nm
WT	29.9 ± 3.0	99.8 ± 35
V924R	26.6 ± 0.3	80.6 ± 7.6